{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:54:03Z","timestamp":1770378843738,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T00:00:00Z","timestamp":1375488000000},"content-version":"vor","delay-in-days":367,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.euroneuro.2011.12.002","type":"journal-article","created":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T18:38:15Z","timestamp":1325270295000},"page":"537-545","source":"Crossref","is-referenced-by-count":14,"title":["Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI"],"prefix":"10.1016","volume":"22","author":[{"given":"M.L.J.","family":"Schouw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.W.A.","family":"Caan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.B.L.M.","family":"Majoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Booij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Nederveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Reneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2011.12.002_bb0005","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/WNR.0b013e3282742115","article-title":"Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study","volume":"18","author":"Anderson","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s002130100729","article-title":"Low-dose citalopram as a 5-HT neuroendocrine probe","volume":"155","author":"Attenburrow","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0010-440X(61)80020-5","article-title":"A systematic investigation of depression","volume":"2","author":"Beck","year":"1961","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF01728311","article-title":"Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease","volume":"24","author":"Booij","year":"1997","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0030","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1528-1167.2006.00502.x","article-title":"Imaging the neural substrates involved in the genesis of pentylenetetrazol-induced seizures","volume":"47","author":"Brevard","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0035","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1176\/appi.ajp.161.7.1181","article-title":"A voxel-based PET investigation of the long-term effects of \u201cecstasy\u201d consumption on brain serotonin transporters","volume":"161","author":"Buchert","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0040","first-page":"38","article-title":"Is correction for age necessary in SPECT or PET of the central serotonin transporter in young, healthy adults?","volume":"47","author":"Buchert","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.STR.31.3.680","article-title":"Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling","volume":"31","author":"Chalela","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0925-4927(99)00048-7","article-title":"Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a coregistered SPECT and MRI study","volume":"98","author":"Chang","year":"2000","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2011.12.002_bb1000","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/clpt.2010.296","article-title":"Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram","volume":"89","author":"Chen","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0055","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.npp.1300683","article-title":"Validation of [123I]-\u00df-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram","volume":"30","author":"de Win","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0269881106063275","article-title":"Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study","volume":"20","author":"de Win","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0065","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/brain\/awn255","article-title":"Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users","volume":"131","author":"de Win","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1192\/bjp.bp.106.035089","article-title":"Neurotoxic effects of ecstasy on the thalamus","volume":"193","author":"de Win","year":"2008","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2011.12.002_bb0075","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/jcbfm.2011.10","article-title":"Intra- and multicenter reproducibility of pulsed, continuous and pseudocontinuous arterial spin labeling methods for measuring cerebral perfusion","volume":"31","author":"Gevers","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00002142-200402000-00003","article-title":"Perfusion imaging using arterial spin labeling","volume":"15","author":"Golay","year":"2004","journal-title":"Top. Magn. Reson. Imaging"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mrm.20338","article-title":"Pulsed star labeling of arterial regions (PULSAR): a robust regional perfusion technique for high field imaging","volume":"53","author":"Golay","year":"2005","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0006-8993(98)01039-7","article-title":"Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging","volume":"813","author":"Hagino","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0095","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1523\/JNEUROSCI.1558-04.2004","article-title":"Mapping dopamine function in primates using pharmacologic magnetic resonance imaging","volume":"24","author":"Jenkins","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0100","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/jcbfm.2010.234","article-title":"Pseudocontinuous arterial spin labeling reveals dissociable effects of morphine and alcohol on regional cerebral blood flow","volume":"31","author":"Khalili-Mahani","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0105","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/brain\/awq103","article-title":"Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography [11C]DASB and structural brain imaging study","volume":"133","author":"Kish","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0006-8993(99)02033-8","article-title":"Effects of the specific serotonin reuptake inhibitor, citalopram, upon local cerebral blood flow and glucose utilisation in the rat","volume":"847","author":"McBean","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0115","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(98)04329-3","article-title":"Positron emission tomographic evidence of toxic effect of MDMA (\u201cecstasy\u201d) on brain serotonin neurons in human beings","volume":"352","author":"McCann","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0120","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.npp.1300736","article-title":"Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB","volume":"30","author":"McCann","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-008-1218-4","article-title":"Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (\u00b1)3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) users: relationship to cognitive performance","volume":"200","author":"McCann","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00213-005-2270-y","article-title":"Neuronal effects of acute citalopram detected by pharmacoMRI","volume":"180","author":"McKie","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0135","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1073\/pnas.87.24.9868","article-title":"Brain magnetic resonance imaging with contrast dependent on blood oxygenation","volume":"87","author":"Ogawa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(02)03243-2","article-title":"Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT receptor binding potential measured by PET using 1A[C-11]WAY-100635","volume":"954","author":"Parsey","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0145","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002130000664","article-title":"The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers","volume":"154","author":"Penttila","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0155","first-page":"36","article-title":"Imaging serotonin and dopamine transporters with [123I]-\u00df-CIT SPECT: binding kinetics and effects of normal aging","volume":"41","author":"Pirker","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0160","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2008.12.032","article-title":"Evidence that increased 5-HT release evokes region-specific effects on blood-oxygenation level-dependent functional magnetic resonance imaging responses in the rat brain","volume":"159","author":"Preece","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0165","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1176\/appi.ajp.157.10.1697","article-title":"Effects of methylphenidate on functional MRI blood-oxygen-level-dependent contrast","volume":"157","author":"Rao","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0170","first-page":"1001","article-title":"MDMA (\u201cecstasy\u201d) and its association with cerebrovascular accidents: preliminary findings","volume":"21","author":"Reneman","year":"2000","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0175","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(01)06888-X","article-title":"Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons","volume":"358","author":"Reneman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00213-006-0334-2","article-title":"The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task","volume":"185","author":"Rose","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0185","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00259-004-1489-x","article-title":"A new model for separation between brain dopamine and serotonin transporters in 123I-\u03b2-CIT SPECT measurements: normal values and sex and age dependence","volume":"31","author":"Ryding","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0893-133X(95)00117-V","article-title":"Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe","volume":"14","author":"Seifritz","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.175.1.63","article-title":"Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (\u2018ecstasy\u2019) users","volume":"175","author":"Semple","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0200","first-page":"678","article-title":"Comparison of (\u00b1)[11C]-McN5652 and [11C]-DASB as serotonin transporter radioligands under various experimental conditions","volume":"43","author":"Szabo","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0205","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuroimage.2005.04.021","article-title":"Quantitative assessment of the reproducibility of functional activation measured with BOLD and MR perfusion imaging: implications for clinical trial design","volume":"27","author":"Tjandra","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2011.12.002_bb0210","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hup.923","article-title":"Sustained attention and serotonin: a pharmaco-fMRI study","volume":"23","author":"Wingen","year":"2008","journal-title":"Hum. Psychopharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11003051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11003051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T11:23:36Z","timestamp":1543317816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X11003051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0924977X11003051"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2011.12.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}